Cryoport Announces Pricing of Public Offering of Units and Listing on NASDAQ

July 23, 2015

Lake Forest, CA, July 23, 2015 - Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (“Cryoport” or the “Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the pricing of an underwritten .>public offering of 2,000,000 units at an offering price of $3.25 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock. The common stock and the warrants are immediately separable, and will trade on The Nasdaq Capital Market under the symbols CYRX, and CYRXW, respectively.  The warrants will have a per share exercise price of $3.57, are exercisable immediately and will expire five years from the date of issuance.

Gross proceeds to Cryoport from this offering are approximately $6,500,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cryoport. Cryoport has granted the underwriters a 45-day option to purchase up to an additional 300,000 units to cover over-allotments, if any. The offering is expected to close on July 29, 2015, subject to customary closing conditions.

Read More

Tags: NASDAQ, Public Offering